drugset / Trial / NCT03302845
A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
RandomizedParallel-groupOpen-labelBasic science
Summary
This drug-drug interaction study will evaluate the impact of two different acid reducing agents (from two different drug classes) co-administered with a single dose of telotristat ethyl.
Timeline
- Start
- 2017-09-21
- Primary completion
- 2017-10-23
- Completion
- 2017-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | 40 mg | — |
| Subject | Omeprazole | Other / unclassified | 40 mg | — |
| Subject | Telotristat Ethyl | Unknown | 250 mg | — |
Indications
No indication recorded.